3rd Party Biotechnology Industry News

The patient who was hospitalized after receiving Intellia Therapeutics’ CRISPR [...]

Twelve years after establishing TechBio company Recursion, co-founder and CEO [...]

Biotech firm prepares for pivotal trials as it positions Teverelix [...]

The FDA has released the second batch of recipients for [...]

More than a year and a half into Cullinan Therapeutics’ [...]

Axsome Therapeutics has wrapped its hands around an epilepsy candidate [...]

UroGen is handing an anti-CTLA-4 antibody back to Agenus after [...]

Amid the rapidly unfolding saga revolving around Metsera, a judge [...]

In a letter to lawyers for Novo and Metsera, an [...]

Novo Nordisk is winding down a range of early-stage programs [...]